tiprankstipranks
Trending News
More News >
Nucana Plc (NCNA)
NASDAQ:NCNA
Advertisement

Nucana (NCNA) Price & Analysis

Compare
1,628 Followers

NCNA Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

11.00%<0.01%0.03%99.97%
11.00%
Insiders
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors

NCNA FAQ

What was Nucana Plc’s price range in the past 12 months?
Nucana Plc lowest stock price was $0.03 and its highest was $10.79 in the past 12 months.
    What is Nucana Plc’s market cap?
    Nucana Plc’s market cap is $20.23M.
      When is Nucana Plc’s upcoming earnings report date?
      Nucana Plc’s upcoming earnings report date is Aug 14, 2025 which is in 20 days.
        How were Nucana Plc’s earnings last quarter?
        Nucana Plc released its earnings results on Jun 02, 2025. The company reported -$0.027 earnings per share for the quarter, missing the consensus estimate of -$0.014 by -$0.014.
          Is Nucana Plc overvalued?
          According to Wall Street analysts Nucana Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Nucana Plc pay dividends?
            Nucana Plc does not currently pay dividends.
            What is Nucana Plc’s EPS estimate?
            Nucana Plc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Nucana Plc have?
            Nucana Plc has 381,295,870 shares outstanding.
              What happened to Nucana Plc’s price movement after its last earnings report?
              Nucana Plc reported an EPS of -$0.027 in its last earnings report, missing expectations of -$0.014. Following the earnings report the stock price went up 50%.
                Which hedge fund is a major shareholder of Nucana Plc?
                Currently, no hedge funds are holding shares in NCNA

                Company Description

                Nucana Plc

                NuCana plc is a clinical-stage biopharmaceutical company focused on developing novel oncology treatment options to improve the lives of patients with cancer. The company is headquartered in Edinburgh, Scotland, and primarily operates in the biotechnology and pharmaceutical sectors. NuCana leverages its proprietary ProTide technology platform to transform chemotherapeutic agents into more effective and safer medicines. Its lead product candidates are currently in various stages of clinical development, targeting a range of cancer types.
                Similar Stocks
                Company
                Price & Change
                Follow
                Scinai Immunotherapeutics
                CNS Pharmaceuticals
                ELEVAI Labs Inc.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis